Oxybutynin is the drug that is in the patch used to help patients with over active bladders and relaxes the organ. A patch can be applied every 4 days. It is the first drug in it’s class to be approved for over the counter use. BD
(Reuters) - Health regulators approved Merck & Co's nonprescription version of Oxytrol to treat overactive bladder in women ages 18 and older, the agency said on Friday.
The U.S. Food and Drug Administration said the over-the-counter version of Oxytrol would be available for women only and that the drug remained available to men by prescription.
Overactive bladder, which affects an estimated 33 million Americans, is a condition in which the bladder squeezes too often or without warning. Symptoms include leaking urine, feeling a sudden and urgent need to urinate, and frequent urination.